Literature DB >> 11312184

Assessment of gadolinium-enhanced time-resolved three-dimensional MR angiography for evaluating renal artery stenosis.

H Masunaga1, Y Takehara, H Isoda, T Igarashi, M Sugiyama, S Isogai, N Kodaira, H Takeda, A Nozaki, H Sakahara.   

Abstract

OBJECTIVE: The purpose of this study was to assess the image quality of gadolinium-enhanced time-resolved three-dimensional (3D) MR angiography and to evaluate its accuracy in revealing renal artery stenosis. SUBJECTS AND METHODS: Thirty-nine patients underwent MR angiography using an ultrafast 3D Fourier transform spoiled gradient-recalled acquisition in the steady state (TR/TE range, 2.6/0.7--0.8). Five seconds after administration of 15--20 mL gadodiamide hydrate, four or five consecutive data sets with imaging times of 7.0--7.6 sec were acquired during a single breath-hold. A timing examination was not performed. Image quality was assessed using quantitative analysis (signal-to-noise, contrast-to-noise, and venous-to-arterial enhancement ratios) and qualitative analysis (presence of venous overlap, presence of artifacts, and degree of renal arterial enhancement). MR angiography depiction of the renal artery stenosis was evaluated using conventional angiography as the standard of reference.
RESULTS: On the best arterial phase, average aortic signal-to-noise ratio (+/-SD) was 74.5 +/- 24.4, aorta-to--inferior vena cava contrast-to-noise ratio was 70.8 +/- 23.4, and inferior vena cava--to-aorta venous-to-arterial enhancement ratio was 0.03 +/- 0.04. No venous overlap was seen in 38 of 39 patients. Substantial enhancement of renal arteries was seen in all patients without any noticeable artifacts. MR angiography correctly depicted the degree of stenosis in 44 of 47 normal arteries, 13 of 16 mildly stenotic arteries, five of five moderately stenotic arteries, three of four severely stenotic arteries, and one of one occluded artery. Sensitivity and specificity for revealing greater than 50% stenosis was 100%.
CONCLUSION: Time-resolved 3D MR angiography can provide high-quality arteriograms. Its performance in revealing renal artery stenosis is comparable with that of conventional angiography.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312184     DOI: 10.2214/ajr.176.5.1761213

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

1.  Quality-evaluation scheme for cerebral time-resolved 3D contrast-enhanced MR angiography techniques.

Authors:  H Raoult; J-C Ferré; X Morandi; B Carsin-Nicol; M Carsin; M Cuggia; M Law; J-Y Gauvrit
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-06       Impact factor: 3.825

2.  Diagnostic value of 3D contrast-enhanced magnetic resonance angiography in Takayasu's arteritis--a comparative study with digital subtraction angiography.

Authors:  Shobhit K Garg; Suyash Mohan; Sunil Kumar
Journal:  Eur Radiol       Date:  2011-02-23       Impact factor: 5.315

3.  MR Venography for the Assessment of Deep Vein Thrombosis in Lower Extremities with Varicose Veins.

Authors:  Kiyoshi Tamura; Hideki Nakahara
Journal:  Ann Vasc Dis       Date:  2014-12-25

4.  Time-resolved MR angiography for detecting and grading ovarian venous reflux: comparison with conventional venography.

Authors:  D M Yang; H C Kim; D H Nam; G H Jahng; C Y Huh; J W Lim
Journal:  Br J Radiol       Date:  2011-03-08       Impact factor: 3.039

5.  Molecular imaging with endogenous substances.

Authors:  Klaes Golman; Jan H Ardenkjaer-Larsen; J Stefan Petersson; Sven Mansson; Ib Leunbach
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

6.  Renal artery stenosis: comparative evaluation of gadolinium-enhanced MRA and DSA.

Authors:  F Stacul; S Gava; M Belgrano; S Cernic; L Pagnan; F Pozzi Mucelli; M A Cova
Journal:  Radiol Med       Date:  2008-05-15       Impact factor: 3.469

7.  Time-resolved contrast-enhanced MR angiography: Value of hemodynamic information in the assessment of vascular diseases.

Authors:  Edyta Maj; Andrzej Cieszanowski; Olgierd Rowiński; Mikołaj Wojtaszek; Małgorzata Szostek; Robert Tworus
Journal:  Pol J Radiol       Date:  2010-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.